{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:55:42Z","timestamp":1790060142893,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center for Cancer and Immunology, Children's Research Institute","award":["Pilot research grant"],"award-info":[{"award-number":["Pilot research grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0262-9","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T13:25:31Z","timestamp":1530710731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Frequency of CD19+CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study"],"prefix":"10.1186","volume":"16","author":[{"given":"Qianzi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-1736","authenticated-orcid":false,"given":"Lawrence K.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"262_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/art.1780390817","volume":"39","author":"LS Peterson","year":"1996","unstructured":"Peterson LS, Mason T, Nelson AM, O'Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum. 1996;39:1385\u201390.","journal-title":"Arthritis Rheum"},{"key":"262_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"262_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/kep144","volume":"48","author":"S Ringold","year":"2009","unstructured":"Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford). 2009;48:972\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1002\/art.27657","volume":"62","author":"MG Barnes","year":"2010","unstructured":"Barnes MG, Grom AA, Thompson SD, Griffin TA, Luyrink LK, Colbert RA, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:3249\u201358.","journal-title":"Arthritis Rheum"},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/art.40410","volume":"70","author":"E Marasco","year":"2018","unstructured":"Marasco E, Aquilani A, Cascioli S, Moneta GM, Caiello I, Farroni C, et al. Switched memory B cells are increased in Oligoarticular and Polyarticular juvenile idiopathic arthritis and their change over time is related to response to tumor necrosis factor inhibitors. Arthritis Rheumatol. 2018;70:606\u201315.","journal-title":"Arthritis Rheumatol"},{"key":"262_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/251550a0","volume":"251","author":"SI Katz","year":"1974","unstructured":"Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature. 1974;251:550\u20131.","journal-title":"Nature"},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","volume":"184","author":"SD Wolf","year":"1996","unstructured":"Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996;184:2271\u20138.","journal-title":"J Exp Med"},{"key":"262_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20021293","volume":"197","author":"C Mauri","year":"2003","unstructured":"Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489\u2013501.","journal-title":"J Exp Med"},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","volume":"176","author":"A Mizoguchi","year":"2006","unstructured":"Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705\u201310.","journal-title":"J Immunol"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129\u201340.","journal-title":"Immunity"},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","volume":"1183","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity. and cancer Ann N Y Acad Sci. 2010;1183:38\u201357.","journal-title":"and cancer Ann N Y Acad Sci"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530\u201341.","journal-title":"Blood"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ajpath.2012.03.010","volume":"180","author":"M Yang","year":"2012","unstructured":"Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012;180:2375\u201385.","journal-title":"Am J Pathol"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5:173ra23.","journal-title":"Sci Transl Med"},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon M, Blair PA, Isenberg DA, Mauri C. A Regulatory feedback between Plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity. 2016;44:683\u201397.","journal-title":"Immunity"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/intimm\/12.5.597","volume":"12","author":"E Mizoguchi","year":"2000","unstructured":"Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597\u2013605.","journal-title":"Int Immunol"},{"key":"262_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.175.1.21","volume":"175","author":"B Knoechel","year":"2005","unstructured":"Knoechel B, Lohr J, Kahn E, Abbas AK. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol. 2005;175:21\u20136.","journal-title":"J Immunol"},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1073\/pnas.0409449102","volume":"102","author":"B Wei","year":"2005","unstructured":"Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, Kronenberg M, et al. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A. 2005;102:2010\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.4049\/jimmunol.174.4.2429","volume":"174","author":"R Brummel","year":"2005","unstructured":"Brummel R, Lenert P. Activation of marginal zone B cells from lupus mice with type a(D) CpG-oligodeoxynucleotides. J Immunol. 2005;174:2429\u201334.","journal-title":"J Immunol"},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10875-005-0355-6","volume":"25","author":"P Lenert","year":"2005","unstructured":"Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005;25:29\u201340.","journal-title":"J Clin Immunol"},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D. Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3:944\u201350.","journal-title":"Nat Immunol"},{"key":"262_CR22","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/eji.201040673","volume":"40","author":"JD Bouaziz","year":"2010","unstructured":"Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010;40:2686\u201391.","journal-title":"Eur J Immunol"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","volume":"147","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815\u201322.","journal-title":"J Immunol"},{"key":"262_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/emboj\/17.4.1006","volume":"17","author":"AM O'Farrell","year":"1998","unstructured":"O'Farrell AM, Liu Y, Moore KW, Mui AL. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 1998;17:1006\u201318.","journal-title":"EMBO J"},{"key":"262_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1084\/jem.185.6.1089","volume":"185","author":"G Grunig","year":"1997","unstructured":"Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 1997;185:1089\u201399.","journal-title":"J Exp Med"},{"key":"262_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cei.12483","volume":"180","author":"LT Aybar","year":"2015","unstructured":"Aybar LT, McGregor JG, Hogan SL, Hu Y, Mendoza CE, Brant EJ, et al. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin Exp Immunol. 2015;180:178\u201388.","journal-title":"Clin Exp Immunol"},{"key":"262_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","volume":"137","author":"Q Simon","year":"2016","unstructured":"Simon Q, Pers JO, Cornec D, Le Pottier L, Mageed RA, Hillion S. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy Clin Immunol. 2016;137:1577\u201384. e10","journal-title":"J Allergy Clin Immunol"},{"key":"262_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","volume":"28","author":"K Yanaba","year":"2008","unstructured":"Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M. Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28:639\u201350.","journal-title":"Immunity"},{"key":"262_CR29","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118:3420\u201330.","journal-title":"J Clin Invest"},{"key":"262_CR30","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3899\/jrheum.131025","volume":"41","author":"L Wang","year":"2014","unstructured":"Wang L, Zhao P, Ma L, Shan Y, Jiang Z, Wang J, et al. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. J Rheumatol. 2014;41:1781\u201392.","journal-title":"J Rheumatol"},{"key":"262_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10067-013-2359-3","volume":"33","author":"L Ma","year":"2014","unstructured":"Ma L, Liu B, Jiang Z, Jiang Y. Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Rheumatol. 2014;33:187\u201395.","journal-title":"Clin Rheumatol"},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10238-014-0310-9","volume":"15","author":"D Cui","year":"2015","unstructured":"Cui D, Zhang L, Chen J, Zhu M, Hou L, Chen B, et al. Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity. Clin Exp Med. 2015;15:285\u201392.","journal-title":"Clin Exp Med"},{"key":"262_CR33","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/art.38666","volume":"66","author":"CI Daien","year":"2014","unstructured":"Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol. 2014;66:2037\u201346.","journal-title":"Arthritis Rheumatol"},{"key":"262_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/rheumatology\/keu136","volume":"53","author":"SK Todd","year":"2014","unstructured":"Todd SK, Pepper RJ, Draibe J, Tanna A, Pusey CD, Mauri C, et al. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford). 2014;53:1693\u2013703.","journal-title":"Rheumatology (Oxford)"},{"key":"262_CR35","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290\u20134.","journal-title":"J Rheumatol"},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/eji.201445082","volume":"45","author":"A Moreau","year":"2015","unstructured":"Moreau A, Blair PA, Chai JG, Ratnasothy K, Stolarczyk E, Alhabbab R, et al. Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival. Eur J Immunol. 2015;45:843\u201353.","journal-title":"Eur J Immunol"},{"key":"262_CR37","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/rheumatology\/keu149","volume":"53","author":"N Lepse","year":"2014","unstructured":"Lepse N, Abdulahad WH, Rutgers A, Kallenberg CG, Stegeman CA, Heeringa P. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology (Oxford). 2014;53:1683\u201392.","journal-title":"Rheumatology (Oxford)"},{"key":"262_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.39820","volume":"69","author":"I Kalampokis","year":"2017","unstructured":"Kalampokis I, Venturi GM, Poe JC, Dvergsten JA, Sleasman JW, Tedder TF. The regulatory B cell compartment expands transiently during childhood and is contracted in children with autoimmunity. Arthritis Rheumatol. 2017;69:225\u201338.","journal-title":"Arthritis Rheumatol"},{"key":"262_CR39","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/art.38736","volume":"66","author":"S Glaesener","year":"2014","unstructured":"Glaesener S, Quach TD, Onken N, Weller-Heinemann F, Dressler F, Huppertz HI, et al. Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66:2590\u2013600.","journal-title":"Arthritis Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0262-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T14:35:12Z","timestamp":1693751712000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0262-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in compliance with the Helsinki Declaration and ethical approval was obtained from the Institution Review Board of Children\u2019s National Medical Center (Pro00005055). All patients were enrolled after obtaining informed consent from parents and assent from patients older than 7\u00a0years old.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"44"}}